GlassScriptPhysician profile
Anthony M Maher
NPI 1982678355
$1,845.02
in general payments reported to CMS, 2019-2025
24 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,303 · 2020: $59.43 · 2021: $105 · 2022: $31.99 · 2024: $42.01 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $435.11 | 2019-2025 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $193.78 | 2019-2025 | Breztri |
| Janssen Pharmaceuticals, INC | $169.95 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.28 | 2019 | |
| Lilly USA, LLC | $109.75 | 2019-2025 | Mounjaro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $100.81 | 2019 | |
| Amgen INC. | $90.25 | 2019-2025 | Krystexxa, Repatha, Otezla |
| Exact Sciences Corporation | $80.85 | 2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $69.75 | 2019 | |
| Merck Sharp & Dohme LLC | $64.41 | 2019 | |
| Pfizer INC. | $63.35 | 2019 | |
| Glaxosmithkline, LLC. | $57.88 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $56.85 | 2019 | |
| Kvk-Tech, INC. | $42.78 | 2019 | |
| Arbor Pharmaceuticals, INC. | $33.04 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $26.26 | 2021 | |
| Shield Therapeutics INC | $24.46 | 2024 | |
| Phadia US INC. | $19.15 | 2022 | |
| Medicure Pharma INC. | $13.47 | 2025 | Zypitamag |
| Kowa Pharmaceuticals America, INC. | $13.06 | 2019 | |
| Cook Medical LLC | $12.84 | 2022 | |
| Antares Pharma, INC. | $12.43 | 2019 | |
| Tms Neurohealth Centers INC. | $11.66 | 2025 | Tms Neurohealth Centers INC. |
| Nalpropion Pharmaceuticals LLC | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Maher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.